WhiteBook2_Part2 - 36
Appendix
RESULTS
Results: Research priorities and preferences of UEG national society members
Table 4. Research priorities identified by each national society
Research domain category
Research topic
category
Drug therapy
Drug therapy
Drug therapy
Drug therapy
Prevention and
control
Assess burden of disease and its
determinants
Health care
quality, access,
and evaluation
Armenian Association of Gastroenterology
Assess burden of disease and its
determinants
Develop new capacities to
reduce burden
Improve performance of existing
capacities to reduce burden
Improve performance of existing
capacities to reduce burden
Improve performance of existing
capacities to reduce burden
Assess burden of disease and its
determinants
Develop new capacities to
reduce burden
Improve performance of existing
capacities to reduce burden
Epidemiology
Drug therapy
Complications
Metabolism
Prevention and
control
Association of Serbian Gastroenterologists ASG
Health care
quality, access,
and evaluation
Diagnosis
Prevention and
control
Crohn's disease and
ulcerative colitis (K50-K51)
Other diseases of liver (K71K77)
Gastritis,
dyspepsia and
other diseases of stomach
and duodenum (K29-K31)
Early diagnosis and
personalised approach in
therapy
Early recognition of NAFLD
Helicobacter pylori infection
All diseases of the digestive
system (K20-K93)
Crohn's disease and
ulcerative colitis (K50-K51)
Other diseases of liver (K71K77)
Other
diseases of liver (K71K77)
Malignant
neoplasms of
digestive organs (C15-C26)
Prevalence, mortality,
outcomes in all GI/liver
disorders
Biologic therapy in IBD, clinical
trials
Outcomes in liver cirrhosis
decompensation
Epidemiology, metabolism,
prevention of NAFLD
Screening programs for gastric,
colorectal, liver cancer
Digestive disease
category
Crohn's disease and
ulcerative colitis (K50-K51)
Irritable bowel syndrome
(K58)
Malignant neoplasms of
digestive organs (C15-C26)
Improve performance of existing
capacities to reduce burden
Improve performance of existing
capacities to reduce burden
Other diseases of liver (K71K77)
Malignant
neoplasms of
digestive organs (C15-C26)
Albanian Association of Gastro-Entero-Hepatology
All diseases of the digestive
system (K20-K93)
All GI and Hepatic Diseases
Description
AEG (Asociación Española de Gastroenterología) and SEPD (Sociedad Española de Patología Digestiva)
Develop new capacities to
reduce burden
Cost-effectiveness analysis of
biologic therapies
Develop new capacities to
reduce burden
Improve performance of existing
capacities to reduce burden
New drugs to treat IBS
Pancreatic cancer drug
treatment
NASH therapeutics
Colorectal cancer screening
White Book 2: Part 2
33
WhiteBook2_Part2
Table of Contents for the Digital Edition of WhiteBook2_Part2
WhiteBook2_Part2 - 1
WhiteBook2_Part2 - 2
WhiteBook2_Part2 - 3
WhiteBook2_Part2 - 4
WhiteBook2_Part2 - 5
WhiteBook2_Part2 - 6
WhiteBook2_Part2 - 7
WhiteBook2_Part2 - 8
WhiteBook2_Part2 - 9
WhiteBook2_Part2 - 10
WhiteBook2_Part2 - 11
WhiteBook2_Part2 - 12
WhiteBook2_Part2 - 13
WhiteBook2_Part2 - 14
WhiteBook2_Part2 - 15
WhiteBook2_Part2 - 16
WhiteBook2_Part2 - 17
WhiteBook2_Part2 - 18
WhiteBook2_Part2 - 19
WhiteBook2_Part2 - 20
WhiteBook2_Part2 - 21
WhiteBook2_Part2 - 22
WhiteBook2_Part2 - 23
WhiteBook2_Part2 - 24
WhiteBook2_Part2 - 25
WhiteBook2_Part2 - 26
WhiteBook2_Part2 - 27
WhiteBook2_Part2 - 28
WhiteBook2_Part2 - 29
WhiteBook2_Part2 - 30
WhiteBook2_Part2 - 31
WhiteBook2_Part2 - 32
WhiteBook2_Part2 - 33
WhiteBook2_Part2 - 34
WhiteBook2_Part2 - 35
WhiteBook2_Part2 - 36
WhiteBook2_Part2 - 37
WhiteBook2_Part2 - 38
WhiteBook2_Part2 - 39
WhiteBook2_Part2 - 40
WhiteBook2_Part2 - 41
WhiteBook2_Part2 - 42
WhiteBook2_Part2 - 43
WhiteBook2_Part2 - 44
WhiteBook2_Part2 - 45
WhiteBook2_Part2 - 46
WhiteBook2_Part2 - 47
WhiteBook2_Part2 - 48
WhiteBook2_Part2 - 49
WhiteBook2_Part2 - 50
WhiteBook2_Part2 - 51
WhiteBook2_Part2 - 52
WhiteBook2_Part2 - 53
WhiteBook2_Part2 - 54
WhiteBook2_Part2 - 55
WhiteBook2_Part2 - 56
https://www.nxtbookmedia.com